SUMMARY The current methods of treatment and reporting are described. The most common form of treatment for gonorrhoea in men and women was a single dose of oral ampicillin, usually 2 g. In proportionately more of the clinics treating women, treatment was given over several days. The wide use of ampicillin represents a marked change in treatment practice during the last decade. Procaine penicillin was the most commonly used parenteral preparation. The two dosages used most often for men were 1-2 and 2-4 megaunits. In women the commonest regimen was 2-4 megaunits and again there was a tendency for treatment to be given over several days. Epidemiological treatment was used widely and in one-third of clinics this occurred without confirmation that the patient was a true contact. Consultants used varying diagnoses on the quarterly returns for patients treated epidemiologically in whom the smears and/or cultures were negative. Most clinics classified these cases as 'other conditions requiring treatment' (D2) but as many as 19 % of clinics designated these cases as being 'true' gonorrhoea. It is suggested that this results in an overestimate of the number of cases of 'real' gonorrhoea treated in England and Wales. 
Introduction
Part 1 of this paper (Adler, 1978) was concerned with the current methods of diagnosis of gonorrhoea used by consultants in England and Wales. This part describes treatment and reporting criteria. Tables 1 and 2 show the various types of treatment used for men and women diagnosed as suffering from gonorrhoea. For both sexes oral and parenteral preparations were used in equal proportions. Penicillin in one of its various forms was used most often.
For men the most commonly prescribed drug was ampicillin, being used in 58 (34%) clinics. In nearly all the clinics (54) a single dose ranging from 0 5 to 3-5 g was given, the commonest dose was 2 g (26 clinics) followed by 1 g (19 clinics) (Figure) . In 53 of the 54 clinics using a single dose of ampicillin this was combined with 1 g of probenecid. In four clinics more than one dose was given, ranging from 1 g a day for three days to 0 5 g four times a day for six days. Three of these clinics also used probenecid.
Procaine penicillin was the most commonly used parenteral preparation. Of the 36 (21 %) clinics for men in which it was used, 30 gave a single dose ranging from 1 2 to 2-4 megaunits. The two dosages most often used were 1 -2 megaunits (11 clinics) and 2 4 megaunits (11 clinics). Probenecid was used less often by clinics in which procaine penicillin was prescribed than by those using ampicillin; with ampicillin it was 98 % (53 out of 54) but with procaine penicillin 50% (15 out of 30). It is also interesting to note that probenecid was used more Figure Distribution of dosages for the the three most commonly used drugs in the treatment of gonorrhoea (once only dosages).
often with higher doses of procaine penicillin than with lower. In six clinics procaine penicillin was used more than once, with doses ranging from 1-2 megaunits daily for two days to 3 megaunits daily for three days. Only one of these clinics used probenecid. Benethamine penicillin, procaine penicillin, and benzylpenicillin (Triplopen) was the parenteral preparation next most often used, being prescribed in 20 (12%) clinics for men. It was usually given as a single dose of 1 25 megaunits (9 clinics) but it was never combined with probenecid. The higher dosage of 2-5 megaunits was used in seven clinics and at this dosage it was more likely to be combined with probenecid. This trend of giving probenecid with higher doses is similar to that found with procaine penicillin. The pattern of treatment for women was similar, with ampicillin being the most commonly used treatment followed by procaine penicillin. As with men the single dosage of ampicillin normally used was 2 g (19 clinics), the next most common was 1 g (17 clinics). However, in proportionately more of the clinics for women treatment was given over several days-10 (18%) out of 55 compared with clinics for men-A (7 %) out of 58. The pattern was also true in relation to treatment with procaine penicillin, but to a lesser extent. The single dose of procaine penicillin most often given was 2-4 megaunits (15 clinics) followed by 1-8 megaunits (9 clinics). Again it was commoner to use higher dosages for women than men. The use of probenecid was similar to that in clinics for men in that it was used in all but one clinic prescribing ampicillin as a single dose, and more often with higher doses of benethamine penicillin, procaine penicillin, and benzylpenicillin than with lower ones.
Epidemiological treatment
In the present study, epidemiological treatment was defined as treatment given to named contacts after a history of exposure but without or in advance of confirmatory pathological findings-namely, treatment in advance of diagnosis. (Table 4 ). In one-third of clinics one of the specified reasons was given, in one-third two were given, and in the final third three or more. In one-third of all the clinics using epidemiological treatment a verbal history of contact was considered an adequate reason for instituting epidemiological treatment; these clinics did not demand a contact slip or seek confirmation from another clinic. In the remaining two-thirds of clinics criteria were more stringent and either a slip or confirmation was required.
It was assumed that the consultants who used epidemiological treatment would examine patients and give tests before instituting therapy. However, this was not always so and in three clinics the physicians did not see the contact and supplied the patient with an extra course of treatment to give to him or her. This procedure cannot be described as epidemiological treatment but constitutes treatment by proxy.
A further important aspect of epidemiological treatment is that concerned with the definitive diagnosis for the quarterly returns. Naturally if the tests for gonoiThoea are returned as positive, the patient is automatically counted as a case. However, it was also considered of interest to establish the eventual diagnosis used when a patient had been treated epidemiologically but the tests were negative. Table 5 shows the diagnostic categories used by clinics when the smears and/or cultures were negative and the patient had already been treated. The diagnostic category most often used was that of 'other conditions requiring treatment' (D2). However, in 19 % of clinics consultants included these cases in the quarterly returns as if they were proved cases of gonorrhoea. (Table 6) . No consultant using this technique counted these as cases of gonorrhoea, but most classified them as 'other conditions requiring treatment'. In 930% of clinics for men and in 77 % of clinics for women using this approach penicillin was prescribed in the form of ampicillin, procaine penicillin, or benethamine penicillin, procaine penicillin, and benzylpenicillin (Triplopen). (Table 7) . The commonest reason was that alcohol irritates the urethra and increases the severity of the symptoms. This is quite different from having a relapse or a post-gonococcal urethritis which was another commonly cited reason. The second commonest reason was that physicians felt abstention from alcohol would lessen the chances of sexual intercourse resulting from the patient's intoxication. Some doctors admitted that they advocated cessation of alcohol since it was standard and historical practice but were not sure that it was of any use.
In two-thirds of clinics one of the reasons was specified and in the remaining third, two of them. FOLLOW-UP TESTS AFTER TREATMENT All patients were seen on at least one further occasion for follow-up tests of cure after treatment (Table 8 ). The only exception to this was one clinic where male heterosexual patients were never seen again. In most clinics patients were seen on three or more occasions for repeat investigations, other than serological tests. (Table 9) . Virtually all the physicians who had microscopical and cultural facilities, and used them, would notify a case if either test was positive.
It was reported (page 13) that in 32 clinics for men and in five for women the diagnosis was made from smears in all or selected patients. In 31 of these clinics the positive smear on its own was considered adequate to identify a case of gonorrhoea, this represents 180% of all clinics in England and Wales.
In seven clinics treatment was given in all or selected instances on empirical or clinical grounds. (Acred et al., 1963; Kunin, 1966) . In addition it is faster and cheaper to administer, less painful to the patient, with little risk of anaphylaxis and sensitisation.
Only two years after the introduction of ampicillin Willcox (1963) was justified in saying that 'oral antibiotic therapy for the treatment of gonorrhoea ... has not so far had the approval of most venereologists'. In 1968 this was confirmed by the study that he carried out for the British Co-operative Clinical Group (1971) into gonorrhoea practices in Great Britain. This study showed that in those clinics prescribing penicillin, procaine penicillin was used particularly often, being given in 57% of clinics for men and 54 % of clinics for women. No clinic used ampicillin on its own. The present study indicates that, less than a decade after this last survey, there has been a marked change in treatment practices. Ampicillin is now the single most common form of treatment, being used in one-third of clinics.
This change is partly because treatment with ampicillin is more acceptable to patients and easier to administer in busy clinics than parenteral preparations. The other important factor is the efficacy of the treatment and it has taken a number of years to establish this. Studies were carried out initially to clarify the most appropriate dosage of ampicillin in the treatment of gonorrhoea (Alergant, 1963; Willcox, 1964) . These studies used single doses of ampicillin but gave conflicting results, Alergant (1963) reporting a low failure rate (5 %) and Willcox a higher one of 15%. This prompted Willcox (1965) to examine whether the drug needed to be given more than once. He showed that ampicillin given M. W. Adler as two doses of 1 g divided by five hours gave better results than a once only dose of 1 g, a finding confirmed by others (Groth and Hallqvist, 1970) . The use of a divided dose raised doubts about patient compliance and prompted other workers to add probenecid to the regimen so that it could be given only once. Gundersen et al. (1969) was the first person to tackle this problem and showed that a combination of 2 g of ampicillin plus 1 g of probenecid given once gave a failure rate of only 1-2%. The final step in the acceptance of ampicillin was in studies that showed that 2 g of ampicillin plus probenecid was as effective as 1-2 megaunits of procaine penicillin plus probenecid Willcox et al., 1973) . Many of these series are not comparable as different follow-up intervals are used after treatment, criteria of treatment failure vary, and information on penicillin sensitivities of the gonococci is not always available.
It is now accepted that if ampicillin is to be used in the treatment of gonorrhoea the most appropriate dosage is a single one of 2 g combined with probenecid. In the present study this was the most commonly used dosage but many clinics were using the lower dosage of 1 g of ampicillin.
The next most common form of treatment was procaine penicillin. In clinics treating men doses of 1 2 and 2-4 megaunits were used equally often, whereas in the clinics treating women the higher dosage was more often used. The fact that clinics treating women tended to use higher dosages is probably a reflection of the difficulty in establishing proof of cure and the concern that they may develop complications-particularly salpingitis. This also accounts for the fact that doctors treating women gave both procaine penicillin and ampicillin in more than one dose more often than for men. Curtis and Wilkinson (1958) reported that the use of long acting penicillin preparations could result in resistant strains of gonococci and asymptomatic carriers. Both of these situations now exist and even though they are not attributable to the use of any particular antibiotic it is surprising that a preparation such as benethamine penicillin, procaine penicillin, and benzylpenicillin (Triplopen) is still being used so widely. After procaine penicillin it was the most common parenteral preparation of penicillin, being used in 12% of clinics for men and in 11 % of clinics for women.
Probenecid was used extensively with ampicillin but less often with procaine penicillin or benethamine penicillin, procaine penicillin, and benzylpenicillin (Triplopen) especially for the smaller dosages. Cobbold et al. (1970) and Rodin and Seth (1972) have reported substantially lower failure rates after treatment with 1 2 megaunits of procaine peni-cillin combined with probenecid than when the same dose is given without probenecid. A dose of 1 2 megaunits of procaine penicillin is a perfectly acceptable level of treatment, but, in view of this work, it should be combined with probenecid much more readily than when using higher dosages when a certain loss of penicillin through renal excretion is less likely to affect the chances of eventual cure.
Co-trimoxazole was the treatment of choice in 90% of clinics, almost all the consultants prescribing treatment over several days. Even though co-trimoxazole has been shown to be effective in the treatment of gonorrhoea (Csonka and Knight 1967; Arya et al., 1970; Carroll and Nicol, 1970; Rodin and Seth, 1972) , there still remains the problem of compliance. Tablets that have to be taken outside the clinic for a number of days are more likely to be thrown away, stopped before the full course is finished, shared with one or more contacts, or used at a later date in an attempt at self-treatment. Tetracycline or triple tetracycline (Deteclo) was used in eight clinics for men and in nine clinics for women. Although reasonable results have been obtained using tetracycline or triple tetracycline in the treatment of gonorrhoea (Smithhurst, 1970; Willcox, 1971) compliance is still a problem. In addition there are concerns in relation to sensitive strains of gonococci and cross resistance 'Because of the rapidity with which less sensitive strains of gonococci develop, and the increasing numbers showing cross resistance it is probably advisable not to use tetracyclines for gonorrhoea at the present time' (Lancet, 1972) .
EPIDEMIOLOGICAL TREATMENT
Although epidemiological treatment was used widely throughout England and Wales, the study was not designed to collect opinions about the efficacy of this approach. This has been debated without resolution by venereologists for a number of years (Willcox, 1954 (Willcox, , 1968 (Willcox, , 1973 King, 1954 King, , 1968 Brown, 1973; King and Nicol, 1975) . It seems probable that epidemiological treatment will continue to be used by physicians, and this being so, the present survey has highlighted a number of areas for concern. In view of the lack of precision of this form of treatment it is essential that the doctor be certain that the patient is a true contact at risk of infection. Consultants working in as many as one-third of clinics prescribing epidemiological treatment did so on the consort's verbal history alone, without the production of a contact slip and without confirming with the other clinic what the diagnosis or treatment had been. Patients are often confused or too overwhelmed to remember their diagnosis or treatment and are therefore unlikely to be able to give exact details to their contacts. Ten years ago a history of treatment by injection would have helped the doctor to establish the most likely diagnosis. But, as has been shown, gonorrhoea is now often treated by tablets and capsules which makes it difficult to differentiate the diagnosis from the more common disease of nonspecific genital infection. It is suggested that, before the institution of epidemiological treatment, clinics should be certain of the disease to which the contact has been exposed. This can be achieved only by requiring the production of a contact slip or telephoning the clinic at which the patient was treated. After 
